Air Liquide Healthcare in the news

The UK antitrust regulator has begun a probe into Vivisol's planned acquisition of Air Liquide Healthcare's home oxygen-services business.

A-Sleep and Air Liquide Healthcare partner to integrate AI-powered sleep apnea diagnostics into home healthcare, improving screening and patient management in Korea and Europe.

A-Sleep and Air Liquide Healthcare are collaborating to integrate A-Sleep's AI-powered sleep apnea diagnostic tool into Air Liquide Healthcare's home healthcare services for expanded screening and management.

A-Sleep and Air Liquide Healthcare partnered to integrate A-Sleep's smartphone-based sleep apnea diagnostic tool, Apnotrack, into Air Liquide's home healthcare systems across 30 countries.

Air Liquide's stock slipped due to an analyst downgrade, despite solid financial performance, continued investment in hydrogen, and a leadership change in its healthcare division.

Vivisol's acquisition of Air Liquide Healthcare's home oxygen-services business is currently being reviewed by the UK Competition and Markets Authority.

Air Liquide reported roughly EUR 28 billion in 2024 revenue, supported by resilient demand in industrial and healthcare sectors, disciplined investments, and strong cash flow.

Air Liquide's 2023 revenue increased by 4.5% to EUR 27.7 billion, fueled by robust demand across industrial gases, healthcare, and electronics, with strategic investments in hydrogen and decarbonization.

Air Liquide reported 2025 sales of EUR 27.06 billion, with a 5.5% increase in Healthcare sales and a 2.2% increase in Industrial Merchant sales.

Air Liquide's stock is supported by stable demand in industrial and healthcare sectors, combined with growth opportunities in electronics and hydrogen, ensuring steady revenue and strong cash flow.

Air Liquide's stock edges higher as investors await new catalysts, recognizing its resilient business model as an industrial-gases and healthcare supplier with exposure to hydrogen and medical gases.

Air Liquide's stock is edging higher as investors track industrial gas demand, valuing its diversified business across industrial, healthcare, and electronics sectors.

Air Liquide, a global industrial and medical gas leader, drives growth through diverse applications, energy transition, and healthcare services.

Air Liquide is expanding its healthcare and aerospace operations with new major contracts while trading at a perceived discount to its intrinsic value.

Air Liquide is expanding its European home healthcare market share through a major Spanish contract for chronic respiratory patient support.

A record-breaking four-year contract has been signed to provide AI-powered home respiratory care for 90,000 patients in Valencia, Spain.

Air Liquide will provide AI-enabled homecare to over 90,000 respiratory patients in Spain's Valencia region under a new four-year contract.

Air Liquide provides industrial and medical gases globally, leveraging long-term contracts in healthcare, electronics, and energy transition sectors to maintain stable earnings.

Air Liquide maintains steady growth through long-term industrial gas contracts and strategic investments in hydrogen, semiconductors, and home healthcare services.

Air Liquide is expanding its European healthcare presence through low-carbon medical gas solutions, strategic acquisitions in Germany, and AI-driven home monitoring for chronic diseases.